Bill

Bill > S1808


NJ S1808

NJ S1808
Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill requires the New Jersey Transit Corporation (corporation) to establish a two-year pilot program, in consultation with the Deputy Commissioner for Public Health Services, to provide an opioid antidote on every light rail train set that operates in the southern part of the State for the purpose of responding to an opioid overdose. Under the pilot program, the corporation is required to: (1) obtain a supply of an opioid antidote and distribute the supply in quantities and types deemed adequate by the corporation, in consultation with the Department of Health, to every light rail train set; (2) maintain one or more secure and easily accessible opioid antidote storage locations on each light rail train set which storage, when opened, is to silently alert the train operator of a potential opioid overdose; (3) stock each storage location with at least two doses of an opioid antidote; (4) ensure that the opioid antidote is appropriately maintained and made available while the light rail train set is in operation and used for light rail service; and (5) mark the location of each supply of the opioid antidote with a prominent sign, in both English and Spanish, and include an information card on how to recognize an opioid overdose, administer the opioid antidote, and contact emergency assistance. In addition, authorized employees of the corporation, contractors, and any other staff members on a light rail train set, are required to: (1) perform routine checks on the opioid antidote locations; (2) maintain a record of the opioid antidote supply on each light rail train set, the maintenance of each location, and any emergency uses of the opioid antidote; and (3) conduct maintenance, as needed. Under the pilot program, an authorized employee, contractor, or any other staff member on light rail train sets, is not required to receive specialized training on how to administer an opioid antidote or administer an opioid antidote in the event of an opioid overdose. Within six months after the expiration of the pilot program, the corporation is required to submit a written report to the Governor and Legislature on the effectiveness of the pilot program and recommendations on whether to implement a permanent program Statewide. This bill appropriates $100,000 from the General Fund to the corporation. The bill expires upon submission of the report.

AI Summary

This bill mandates that the New Jersey Transit Corporation (NJT) establish a two-year pilot program to equip every light rail train set operating in southern New Jersey with an opioid antidote, which is a medication approved by the FDA to treat opioid overdoses, such as naloxone. The program requires NJT to secure and distribute adequate supplies of these antidotes, store at least two doses in secure, easily accessible locations on each train set that silently alert the operator to a potential overdose, and ensure the antidotes are maintained and available during operation. Prominent signs in English and Spanish, along with informational cards on recognizing overdoses and administering the antidote, will be posted. While train operators will be instructed to contact emergency services if alerted, authorized employees and contractors are not required to administer the antidote or undergo specialized training, but they must perform routine checks, maintain records of supply and usage, and conduct necessary maintenance. Following the pilot, NJT must submit a report to the Governor and Legislature on the program's effectiveness and recommendations for a statewide rollout, and $100,000 is appropriated to cover implementation costs.

Committee Categories

Transportation and Infrastructure

Sponsors (2)

Last Action

Introduced in the Senate, Referred to Senate Transportation Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...